hrcak mascot   Srce   HID

Croatian Journal of Infection, Vol.31 No.1 March 2011.

Review article

Macrolides – more than antibiotics

Vesna Eraković Haber ; Galapagos istraživački centar d.o.o. Zagreb

Fulltext: croatian, pdf (181 KB) pages 29-39 downloads: 991* cite
APA 6th Edition
Eraković Haber, V. (2011). Makrolidi – više od antibiotika. Infektološki glasnik, 31 (1), 29-39. Retrieved from https://hrcak.srce.hr/66761
MLA 8th Edition
Eraković Haber, Vesna. "Makrolidi – više od antibiotika." Infektološki glasnik, vol. 31, no. 1, 2011, pp. 29-39. https://hrcak.srce.hr/66761. Accessed 18 Jul. 2018.
Chicago 17th Edition
Eraković Haber, Vesna. "Makrolidi – više od antibiotika." Infektološki glasnik 31, no. 1 (2011): 29-39. https://hrcak.srce.hr/66761
Harvard
Eraković Haber, V. (2011). 'Makrolidi – više od antibiotika', Infektološki glasnik, 31(1), pp. 29-39. Available at: https://hrcak.srce.hr/66761 (Accessed 18 July 2018)
Vancouver
Eraković Haber V. Makrolidi – više od antibiotika. Infektološki glasnik [Internet]. 2011 Mar 31 [cited 2018 July 18];31(1):29-39. Available from: https://hrcak.srce.hr/66761
IEEE
V. Eraković Haber, "Makrolidi – više od antibiotika", Infektološki glasnik, vol.31, no. 1, pp. 29-39, July 2018. [Online]. Available: https://hrcak.srce.hr/66761. [Accessed: 18 July 2018]

Abstracts
Macrolide antibiotics play an important role in the treatment of infectious diseases because of their relatively broad antimicrobial spectrum and good safety profile. A wide usage of macrolides has lead to certain clinical observations which cannot be explained by direct antibiotic action. There are numerous reports on macrolide effect in chronic inflammatory diseases, such as diffuse panbronchiolitis, cystic fibrosis, bronchiolitis obliterans syndrome, etc. Intensive preclinical and clinical research have shown that macrolides exhibit immunomodulatory activity and that macrolide-induced inhibition of Pseudomonas aeruginosa virulence factor production and biofilm formation is responsible for some of the effects. Beneficial results of the immunomodulation, increased survival rate and decreased hospital stay, have been reported for community acquired pneumonia and sepsis. It is up to clinicians to recognise further opportunities to exploit macrolide immunomodulation, whereas drug-discovery research efforts, based on reverse pharmacology approach, should be directed towards discovery of new immunomodulatory macrolides lacking antimicrobial activity.

Keywords
macrolides; immunomodulation; inflammation

Hrčak ID: 66761

URI
https://hrcak.srce.hr/66761

[croatian]

Visits: 3.763 *